Can You Feel the Excitement? Kamala Is Back and in the Lead!
Bad News: Abigail Spanberger Is Governor of Virginia. Good News: A Savior Might...
The AI Race Needs a Little More ‘I’ in It
A Republican Who Wants to Raise Taxes
Welcome to the Old World Order
The Midterms: It's Not About 'Affordability' -- It's About Trump Hatred
Trump’s First Year Delivered the Most Meaningful Education Reforms in Decades
Pro-Abortion James Talarico's Factless Campaign for the Senate
How America First Policies Can Lead to Even More Growth in 2026
If You Own It, You Should Be Able to Fix It
Minnesota Malfeasance Is a Preview of Biden-Era Fraud and Waste
Why Children Under 13 Should Be Banned From Social Media
A Refreshing Year for LGBT Conservatives
Jury Convicts Alleged Minneapolis Gang Member in Fatal Gas Station Attack
Former TD Bank Worker Helped Launder $26 Million Through Shell Accounts, Prosecutors Say
Tipsheet

Tulsi Gabbard: The Biden Administration Is Promoting Child Abuse

(AP Photo/John Minchillo)

Former Democratic Congresswoman Tulsi Gabbard took to her social media pages over the weekend to highlight a new Food and Drug Administration warning about puberty blockers. 

Advertisement

According to the FDA, these drugs can cause blindness and other permanent injuries when taken by children. 

The Food and Drug Administration (FDA) has added a warning about the risk of pseudotumor cerebri (idiopathic intracranial hypertension) to the labeling for gonadotropin-releasing hormone (GnRH) agonists that are approved for the treatment of central precocious puberty in pediatric patients. These products include Lupron Depot-Ped (leuprolide acetate), Fensolvi (leuprolide acetate), Synarel (nafarelin), Supprelin LA (histrelin) and Triptodur (triptorelin).

The new warning includes recommendations to monitor patients taking GnRH agonists for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred or loss of vision, diplopia, pain behind the eye or pain with eye movement, tinnitus, dizziness and nausea.

The FDA assessed the potential risk of pseudotumor cerebri with use of GnRH agonists in pediatric patients by reviewing post-marketing safety data submitted by the GnRH agonist manufacturers, searching the FDA Adverse Event Reporting System and conducting a literature search.

Advertisement

Related:

JOE BIDEN

For months the Biden administration has been in a full court press to "affirm" gender "care" for children. That so-called "care" includes using taxpayer dollars to pay for puberty blockers and medical castration for young kids through Medicaid. 

"Providing resources on the importance of gender affirming care for children and adolescents. The Office of the Assistant Secretary for Health has developed a resource to inform parents and guardians, educators, and other persons supporting children and adolescents with information on what is gender-affirming care and why it is important to transgender, nonbinary, and other gender expansive young people’s well-being," the White House released in a March "fact sheet." 

Biden's U.S. Assistant Secretary of Health Dr. Levine has repeatedly stressed the "necessity" for children to be encouraged to use these kinds of drugs. 

Advertisement

During Levine's confirmation hearing, Republican Senator Dr. Rand Paul asked about Levine's support for these dangerous drugs. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos